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of complex interventions: a proposed framework
for design and reporting
Aileen Grant1*, Shaun Treweek1, Tobias Dreischulte2, Robbie Foy3 and Bruce Guthrie1Abstract
Background: Process evaluations are recommended to open the ‘black box’ of complex interventions evaluated in
trials, but there is limited guidance to help researchers design process evaluations. Much current literature on
process evaluations of complex interventions focuses on qualitative methods, with less attention paid to
quantitative methods. This discrepancy led us to develop our own framework for designing process evaluations of
cluster-randomised controlled trials.
Methods: We reviewed recent theoretical and methodological literature and selected published process
evaluations; these publications identified a need for structure to help design process evaluations. We drew upon
this literature to develop a framework through iterative exchanges, and tested this against published evaluations.
Results: The developed framework presents a range of candidate approaches to understanding trial delivery,
intervention implementation and the responses of targeted participants. We believe this framework will be useful to
others designing process evaluations of complex intervention trials. We also propose key information that process
evaluations could report to facilitate their identification and enhance their usefulness.
Conclusion: There is no single best way to design and carry out a process evaluation. Researchers will be faced
with choices about what questions to focus on and which methods to use. The most appropriate design depends
on the purpose of the process evaluation; the framework aims to help researchers make explicit their choices of
research questions and methods.
Trial registration: Clinicaltrials.gov NCT01425502
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ReportingBackground
Many interventions to improve healthcare delivery and
health are complex in the sense that they possess several
interacting components [1]. Randomised controlled trials
of such interventions are often criticised as being ‘black
box’, since it can be difficult to know why the intervention
worked (or not) without examining underlying processes.
As a result, reported effects of what appear to be similar
interventions often vary across studies because of differ* Correspondence: a.m.grant@dundee.ac.uk
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reproduction in any medium, provided the orences in context, targeted groups and the intervention ac-
tually delivered [2,3]. The UK Medical Research Council
guidance for developing and evaluating complex interven-
tions recommends conducting a process evaluation to
‘explain discrepancies between expected and observed
outcomes, to understand how context influences out-
comes, and to provide insights to aid implementation’ [1].
Although our focus is on randomised trials, it is important
to recognise that similar issues arise in the evaluation of
public health interventions which may use a range of dif-
ferent evaluative designs [4-6].
In complex intervention trials, the intervention to be
evaluated may be delivered at different levels: the inter-
vention can be delivered straight to the patient, such astd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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physical activity interventions on adults [7]; the interven-
tion can be delivered to the healthcare professional, for
example in trials of decision support tools [8]; or the inter-
vention can be targeted at the organisational level, such
as in a recent trial testing a pharmacist-led information-
technology-based intervention aimed at optimising medi-
cation safety systems in general practice [9] (adapted from
the Medical Research Council guidance 2000) [10].
Process evaluations are studies that run parallel to or
follow intervention trials to understand the trial pro-
cesses or underlying mechanisms in relation to context,
setting [11], professionals and patients [12]. These eva-
luations provide explanations for the trial results and
enhance understanding on whether or how interventions
could move from research to practice.
We planned to conduct a parallel process evaluation
of a cluster-randomised trial of a complex intervention
to improve prescribing safety [13] targeted at general
practices. Although there is clear published guidance for
designing trials where clusters rather than individuals
are the unit of randomisation [14,15], we found the
Medical Research Council guidance of limited help in
designing the process evaluation of our trial.
In our trial, the research team delivers an intervention
to general practices – with the intention of prompting
those practices to review patients with particular types
of high-risk prescribing (nonsteroidal anti-inflammatory
drugs or antiplatelets), to carefully reconsider the risks
and benefits of the offending drugs in each patient and
to take corrective action where possible [13]. There is
therefore an intervention delivered to practices (the
cluster) that hopes to change the behaviour of practi-
tioners. This approach is similar to most trials of audit
and feedback [16] and to many trials involving a profes-
sional training intervention, as in the OPERA trial where
a training intervention is delivered to nursing home staff
and physiotherapists who deliver an intervention of
physical activity and physiotherapy to residents of resi-
dential and nursing homes [17,18]. In other trials, how-
ever, the intervention is delivered to individuals by the
research team themselves, as in a trial of body weight
and physical activity for adults at risk of colorectal aden-
omas [7]. Process evaluations therefore need to be tai-
lored to the trial, the intervention and the outcomes
being studied, but we could not find clear guidance in the
literature on how to do this. Additionally, we noted wide
variations in the aims, methods, timing and reporting of
process evaluation studies that made it difficult to draw
on them in designing our own process evaluation.
We therefore developed a framework to guide the
design of our own process evaluation. We believe it may
be of help to other cluster triallists faced with a similar
task. We also make proposals for the reporting of processevaluations to enhance their identification and usefulness
to other researchers.
Methods
Existing literature
To support the design of our own process evaluation, we
wanted to identify relevant methodological and theore-
tical literature. We did not aim for a comprehensive
review of all such studies but rather sought to gain a
general understanding of this literature. We were par-
ticularly interested in the purpose and the design of
process evaluations of cluster-randomised controlled
trials. Our initial search (which included the terms
‘process evaluation’ or ‘qualitative’ or ‘quantitative’ and
‘complex intervention’ or ‘randomised controlled trial’)
in Medline, Embase, Psycinfo, Cochrane Central Register
of Control Trials and Cochrane Database of Systematic
Reviews was informative but identified studies that
tended to focus on a specific aspect of process evalua-
tion design or the nature of process evaluations and
qualitative methods. There was little guidance on how to
design a process evaluation. We turned to process evalua-
tions from cluster-randomised controlled trials identified
by our search from which we could learn. We designed a
data extraction form based on the Reach, Efficacy, Adop-
tion, Implementation and Maintenance (RE-AIM) frame-
work [19] and Northstar [20] to summarise identified
reports of process evaluations in terms of: the aim of the
work; the timing (parallel to the trial or post hoc); its scope
with reference to each RE-AIM construct (reach, efficacy,
adoption, implementation and maintenance) and the
methods used; and trial and process evaluation findings
and how they were reported. This form was systematically
populated with information from all identified process
evaluations by AG, with a second review of each by either
ST, RF or BG. Disagreements between reviewers were col-
lectively discussed and resolved, and general strengths and
limitations in design and reporting were identified.
We initially set out to design a critical appraisal form
but there was wide variation in the reporting of process
evaluations that made consistent critical appraisal diffi-
cult. We struggled to make judgements based on the
breadth of information reported in our data extraction
form because we found studies that chose to report one
process in detail but did say if other processes had been
considered and an explicit judgement had been made
not to evaluate them [21]. Some general features of this
literature are summarised below.
Results and discussion
Process evaluation purpose
The generally agreed purpose of process evaluations of
trials of complex and public health interventions is to
understand the effects (or not) of interventions [2-4].
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lidity by delineating key intervention components (con-
struct validity), and by demonstrating connections between
the intervention and outcomes (internal validity) and be-
tween the intervention and other contexts (external vali-
dity) [4,22]. Implementation and change processes can be
explored [1,23], and factors associated with variations in
effectiveness can be examined [24]. Process evaluations can
also examine the utility of theories underpinning interven-
tion design [25] and generate questions or hypotheses for
future research. Process evaluations can therefore fulfil a
variety of purposes, including understanding intervention
effects, potential generalisability and optimisation in routine
practice [26].
Process evaluation design
Published papers on trial process evaluation design largely
focus on qualitative research methods [3,23,27], but many
of the purposes identified above can be assessed both quan-
titatively and qualitatively; indeed, process evaluation of
public health interventions often explicitly uses mixed
methods [4]. The focus on qualitative methods in trials may
occur because many routinely collect some quantitative
process data measures to fulfil Consolidated Standards of
Reporting Trials (CONSORT) requirements or as secon-
dary outcomes, rather than as part of a distinct process
evaluation. For example, data on recruitment are likely to
be collected and reported as part of the main trial because
reporting these data is a CONSORT requirement [28], but
for many trials a more detailed examination of the process
of recruitment may be useful, to inform interpretation of
trial results and generalisability.
Process evaluation reporting
We found it difficult to systematically identify process eva-
luations of complex intervention trials, and the reporting
of important information was also variable. Although
some papers were easily identifiable and had clearly stated
purposes and methods [21,29,30], others:
 were hard to identify because of a lack of explicit
labelling:
 lacked clarity about their overall purpose or did not
state specific objectives:
 did not clearly state whether the evaluation was pre-
planned and carried out in parallel to the main trial
or was conducted post hoc:
 did not provide an explicit statement of the main
trial findings, making it difficult to judge the
relevance and implications of the process evaluation.
Overall, although the existing literature was often
thought-provoking, it did not provide an over-arching
framework for designing process evaluations.Framework for designing process evaluations of cluster-
randomised trials of complex interventions
In developing our framework we drew upon the general li-
terature on process evaluation and the RE-AIM framework
[3,11,19,23,26,27,31], and on published process evaluations
[11,12,21,29,32,33]. The framework was developed by all
the authors through iterative meetings, redefining and
working with the concepts and testing this work against
published evaluations.
Cluster-randomised designs are utilised when individual
randomisation is not possible, feasible or appropriate,
mainly because of potential contamination between the
intervention and control arms [34]. Following the most
recent CONSORT extension for cluster-randomised trials
[28], we distinguish between individuals in the target
population on whom outcome data are collected and
‘clusters’, which are some larger social unit within which
individuals are nested and where the cluster is the unit of
randomisation. Clusters may be defined by geography,
institution, teams or services within institutions, or by
individual professionals delivering a service to patients.
Although outcomes are collected on an individual level,
the primary unit of inference of the intervention may be
the individual or the cluster, depending on the purpose of
the study and the primary outcome measures. The focus
of a process evaluation will vary with the nature of the
trial and resources available, so although several key pro-
cesses are candidates for examination in any evaluation of
cluster trials (Figure 1), the importance of studying them
will vary between trials. Also important to note is the fact
that although the emphasis in what follows is on processes
in clusters that receive the intervention, it will usually be
equally important to understand relevant processes in
control or usual care clusters.
Recruitment of clusters (areas, institutions, individual
professionals)
How clusters are sampled and recruited is important to
help understand how generalisable the findings are likely
to be. At a minimum, recruitment is likely to be moni-
tored to fulfil CONSORT requirements for reporting
findings of the main trial [28], but a more in-depth
understanding of why clusters participate (or not) can
inform the interpretation and implementation of trial
findings.
Delivery to clusters
In some trials, the research team or specially trained
professionals may deliver a complex intervention to in-
stitutional or individual professional clusters, which are
then expected to change their practice or service deli-
very in some way that impacts on the individuals in the
target population. Understanding the nature of cluster-
level interventions and variations in their delivery may
Figure 1 Framework model for designing process evaluations of cluster-randomised controlled trials.
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tional clusters.
Response of clusters
Response is the process by which clusters such as institu-
tions or individual professionals integrate and adopt new
trial-related or intervention-related work into their existing
systems and everyday work, and will be influenced by how
the research team engages and enrols the clusters and by
the extent to which the work is perceived to be legitimate
within organisations or by individual professionals [35].
Recruitment and reach of individuals
Interpretation of the intervention’s measured effective-
ness in the trial will depend on recruitment and reach,
in terms of the proportion of the target population that
actually receives the intervention, and how representa-
tive they are. Variation in the response of clusters will
affect how clusters identify and enrol these individuals.
When recruitment of individuals is carried out by orga-
nisational or individual professional clusters, there is
potential for selection bias [34] – although similar issues
arise in clusters defined by geography, where a variableproportion of the population may receive a public health
intervention [4]. As well as influencing effectiveness,
if high or representative recruitment and reach is not
achieved within clusters in the trial, then the population
impact of implementation in routine practice is likely to
be limited.
Delivery to individuals
In some studies, a complex intervention is delivered to
the target population of individuals. Such interventions
may be tightly defined by the researchers [36], in which
case evaluation of delivery to individuals in the target
population may focus on how closely the intervention
delivered matches what the researchers intended (usually
called the fidelity of the intervention) and the impact of
deviation on effectiveness. In some trials, such as those
on guideline implementation strategies, the intervention
is not directly delivered to individuals (patients) but in-
stead aims to change professional behaviour. The nature
of the changes to work patterns or professional beha-
viour at the individual or patient level can be examined
to better understand why it succeeded or failed. For ex-
ample, in our trial the Data-driven Quality Improvement
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general practitioners to improve prescribing safety. This
intervention prompts practitioners to carry out a targeted
medication review based on a guideline provided to them,
but practitioners are free to review medication in any way
they judge appropriate [13]. Understanding how practi-
tioners actually carry out these medication reviews is there-
fore likely to be important to explaining the trial results.
Response of individuals
The effectiveness of many but not all interventions will be
mediated by the responses of the targeted individuals, par-
ticularly where effectiveness is strongly influenced by ad-
herence or requires behaviour change in those individuals.
Similar to understanding the response of organisational or
individual professionals to interventions directed at them,
it may be helpful to draw on prior [37] or other relevant
theory [38] to examine individual responses.
Maintenance
Understanding whether and how each of the above pro-
cesses is maintained or sustained over time is important, es-
pecially for studies of longer duration. Organisational
clusters or individuals may cease to participate completely
or the way in which they adopt and respond to the inter-
vention may change over time, such as with declining reach
or changes in the nature of the intervention delivered.
Effectiveness
Although pre-specified measurement of effectiveness is the
primary function of the main trial, the process evaluation
can examine associations between trial processes and
effects on primary and secondary outcomes – recognising
that these are exploratory analyses. This can help explain
why an intervention did or did not work, and can explore
variations in effectiveness between clusters that may be im-
portant in planning more widespread implementation.
Unintended consequences
All interventions have the potential to produce unintended
consequences, which may be beneficial or harmful. Process
evaluations provide an opportunity to systematically iden-
tify and quantify unexpected unintended outcomes.
Theory
If theory has been used to develop the intervention, then
this should be made explicit, and the process evaluation
can examine whether predicted relationships and sequences
of changes happen during implementation. Causal model-
ling based on psychological theory is an example that
would apply to ‘delivery to the individual’ and ‘response of
individuals’ [37]. Even if interventions do not have a strong
theoretical base, then it may be useful to draw on relevant
theory to help understand their effects [35].Context
Irrespective of which specific processes are examined, a
careful description of the context in which the trial is
embedded will usually be helpful for interpreting the
findings, including how generalisable any findings are
[39]. Additionally, trials are often conducted in different
contexts – for example, within different health boards or
different countries – and so consideration of these local
contexts may be important. Each of the concepts in the
model has contextual factors that may act as barriers
and/or facilitators to implementation. For example, the
DQIP trial is delivered in two health boards within
Scotland that have different pre-existing levels of pre-
scribing improvement support for practices, and this
support has a different focus in each board. As well as
the wider context of the organisation of primary health-
care in the United Kingdom being important, these local
contextual factors may modify how practices respond to
the same intervention [13,40].
Applying the framework to different types of trial
As described above, cluster-randomised trials vary
greatly in their design, including the level at which inter-
ventions are targeted. The framework can therefore be
seen as a set of candidate elements for designers of
process evaluations to consider. The relevance and rela-
tive importance of candidates will vary between trials,
the aim and objectives of the evaluation and whether the
authors plan to pre-specify their data collection and ana-
lysis (potentially allowing hypothesis testing) or conduct
the evaluation post hoc (for example, depending on the
experience of conducting the trial or on the trial results,
in which case the evaluation can only be hypothesis
generating). Inevitably, resource limitations will often
require a focus on elements that are considered most
critical in the context being evaluated. In such cases,
emphasis should be placed on collecting quality data for
a few key processes rather than collecting a lot of data
for each candidate process. The following section dis-
cusses how the framework may be applied.
Research methods for process evaluations of cluster-
randomised trials
The appropriate methods for a process evaluation will
depend on the intervention being evaluated and the aims
of the evaluation. Table 1 presents examples of research
questions that could be asked within each domain and
methods to answer these questions. Both qualitative and
quantitative methods can be appropriate depending on
the questions asked. Quantitative data collection will be
required if it is judged that all clusters should be evalua-
ted in large multisite trials [3], whereas sampling may be
necessary for more in-depth qualitative evaluation.
Mixed methods can add complementary insights. For
Table 1 Example research questions and methods for evaluating each process
Domain Example research questions Research methods that could be applied Probable best
stage of study to
collect data
Recruitment of
clusters
How are clusters sampled and recruited? Documentation of recruitment process by research team. Pre-intervention
Who agrees to participate? Quantitative comparison of recruited and nonrecruited
clusters.
Why do clusters agree to participate (or not) Qualitative analysis of interviews with cluster gatekeepers or
members.
Delivery to
clusters
What intervention is actually delivered for each
cluster? Is it the one intended by the
researchers?
Qualitative analysis of observational, interview and
documentary data relating to the cluster-level intervention.
Pre-intervention
and early
intervention
Response of
clusters
How is the intervention adopted by clusters? Quantitative data measuring cluster members’ perceptions
of the intervention and uptake of trial components.
Qualitative analysis of observational, interview and
documentary data about how clusters adopt the
intervention.
Pre-intervention
and early
intervention
Recruitment
and reach in
individuals
Who actually receives the intervention in each
setting? Are they representative?
Measurement of receipt in target population. Quantitative
comparison of those receiving vs. not receiving the
intervention.
During
intervention
Why do clusters achieve the pattern of reach
they do? Do they introduce selection bias?
Qualitative analysis of observational, interview and
documentary data about how clusters achieve reach.
Delivery to
individuals
What intervention is actually delivered for each
cluster?
Qualitative analysis of observational, interview and
documentary data about what intervention is delivered and
why.
During
intervention
Is the delivered intervention the one intended
by the researchers?
Measurement of intervention fidelity across its components.
Response of
individuals
How does the target population respond? Qualitative analysis of observational and interview data
about target population’s experience of and response to
the intervention.
During
intervention and
post-intervention
Maintenance How and why are these processes sustained
over time (or not)?
Any of the above, but probably focused on processes
identified as critical, or as likely to be difficult to sustain.
During
intervention and
post-intervention
Unintended
consequences
Are there unintended changes in processes and
outcomes, both related to the trial intervention
and unrelated care?
Qualitative analysis of observational and interview data for
identification. Quantitative data collection for potential
unintended consequences during the trial, or use of routine
datasets.
Intervention and
post-intervention
Theory What theory has been used to develop the
intervention?
Quantitative process data analysis can assess whether
predicted relationships and sequences of change happened
during implementation.
Post-intervention
Context What is the wider context in which the trial is
being conducted?
Qualitative data collection from policy documents or
interviews.
Pre-intervention
and early
intervention
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of an intervention to the target population could be
examined using qualitative analysis of interview and
observational data, with variation in outcome across
clusters examined quantitatively. Similarly, a study that
seeks to explore individuals’ receipt of and response to
an intervention can initially use quantitative data to
inform sampling strategies and qualitative methods to
explore different experiences (potentially at different
stages of implementation). For some purposes, explicitly
theoretical approaches to design and analysis will be
appropriate, such as the use of psychological theory to
understand individual behaviour [21], or sociological
approaches to understanding response in different contexts,
such as realistic evaluation or normalisation process theory[11,35]. Even without explicit use of theory, however, a
process evaluation can productively draw on the resear-
chers’ implicit models of how an intervention is expected
to work [30,41]. Although the right design and method will
therefore depend on the purpose of the evaluation, which
will vary with the trial design and context, it is critical that
the choices made and the rationale behind them is made
explicit.
Reporting process evaluations
The framework systematically identifies cluster-randomised
trial processes that are candidates for evaluation. In prac-
tice, choices will often have to be made that balance the
ideal with the feasible, focusing attention and available
resources on key research questions. More systematic
Table 2 Mapping of the reporting framework to three selected process evaluations
Summary of trial
being evaluated
Clearly
labelled
as a
process
evaluation
Stated purpose Processes
examined
Specify
timing
Methods used Choice
of
method
justified
Report
main
findings of
trial
Nazareth
and
colleagues
[30]
Cluster-
randomised trial
of a pharmacist-
led educational
outreach
intervention to
improve GPs’
prescribing quality
Yes ’To describe the
steps leading to
the final primary
outcome and
explore the effect
of the intervention
on each step of
the hypothesised
pathway of
change in
professionals’
prescribing
behaviour’
Cluster
recruitment,
Delivery to
clusters, Adoption
and Delivery to
target population,
Quantitative
associations with
effectiveness
(reported in main
trial paper)
Retrospective/
post hoc
Reporting of
proportion of
practices recruited.
Association
between
proportion of GPs
in each practice
attending
education
outreach, the
intervention and
change in
prescribing. Mixed-
methods
assessment of
barriers and
facilitators to
adoption and
delivery to target
population.
Partly Trial design,
intervention,
targeted
outcomes
and results
summarised,
main trial
paper
referenced
Byng and
colleagues
[11]
Cluster-
randomised trial
of a complex
intervention to
promote shared
care for people
with severe
mental health
problems
Yes ’To unpick the
complexity of the
intervention by
examining
interactions
between
components and
context and then
further defining its
core functions’
Adoption, Reach
and Delivery to
target population,
Qualitative
associations with
effectiveness
Retrospective
data
collection,
unclear if
planned
prospectively
Realistic
evaluation,
qualitative case
study, analysis of
interview data
with a purposive
sample of
participating
mental health
team-practice
cases. Case study
findings were used
to better
understand how
the intervention
changed practice
and targeted
outcomes.
Yes Trial design,
intervention
and results
summarised,
main trial
paper
referenced
Fretheim
and
colleagues
[33]
Cluster-
randomised trial
of a multifaceted
intervention
(educational
outreach, audit
and feedback,
computerised
reminders, patient
information) to
improve GPs’
prescribing quality
Yes ’The main
objective of this
analysis was to
identify factors
that could explain
variation in
outcomes across
practices’
Delivery to
clusters, Adoption
and Quantitative
associations with
effectiveness
Prospective /
pre-specified
Quantification of
GP perceptions of
the intervention
and the trial, and
pharmacist
assessment of the
quality of
educational
outreach.
Regression analysis
of associations
with change in
prescribing.
Partly Trial design,
intervention,
targeted
outcomes
and results
summarised,
main trial
paper
referenced
GP, general practitioner.
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for choices more explicit, improving interpretation. We
believe that this key information includes the following
factors:
Process evaluations should be clearly labelled. Existing
process evaluation studies are poorly labelled and hard to
identify.Process evaluations should clearly state their purpose.
Process evaluations should explicitly state their original
purpose and research questions, the processes being
studied and an acknowledgement of what is not being
evaluated [21]. Changes to research questions during the
study can be legitimate but should be explicit. For ex-
ample, a pre-planned examination of recruitment and
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ing unexpected variation in intervention delivery.
Process evaluations should clearly report if they were
pre-specified or post hoc, and why the selected timing
was chosen. Pre-specified and post-hoc process evalua-
tions are both legitimate designs. Pre-specified evalua-
tions are more suited to quantitatively examine prior
hypotheses about trial processes, whereas post-hoc eva-
luations are more flexible for examining unanticipated
problems in implementation or unexpected findings.
Again, clarity in what was done and why is key to inter-
preting the validity and credibility of the findings.
Process evaluations should state the choice of methods
and justify them in terms of the stated aims of the eva-
luation. The rationale for the methods used should be
reported in relation to evaluation aims.
Process evaluations should summarise or refer to the
main findings of the trial. To aid interpretation of evalu-
ation findings, trial and evaluation reports should cross-
reference each other and process evaluations should
summarise the main trial findings.
Table 2 maps our proposed design and reporting frame-
work to three process evaluations that were broad and
detailed in reporting their process evaluation and that we
judged to significantly add understanding to the main trial
findings. These vary considerably in their purpose,
whether they were prospective or retrospective, the pro-
cesses examined and the methods used. We believe our
framework helps clarify what kind of process evaluation
they were, including the processes they do not examine
(which is not always explicit in the original papers).
Conclusion
There are a number of approaches to the design of
process evaluations of randomised trials in the literature
[1-3,11,19,23,26,27,31,35,37] and other additional rele-
vant literature related to public health interventions
where randomisation is often not used. Our framework
pulls many smaller design considerations together into a
comprehensive overview of candidate elements that are
potentially relevant to the design of process evaluations
of cluster-randomised trials of complex interventions.
The framework draws attention to a wider range of pro-
cesses that can be evaluated than many of the existing
approaches, which only apply to some of these elements,
although they do offer useful ways of examining these in
depth. For example, normalisation process theory [35]
maps well to some candidates of our framework, such as
‘response of clusters’, ‘delivery to individuals’ and ‘main-
tenance’, and facilitates a more in-depth sociological ex-
ploration of these candidates. Hardeman and colleagues’
causal modelling approach [37] maps well to ‘response
of individuals’ and facilitates a more in-depth psycho-
logical exploration of this candidate. The RE-AIMframework focuses on the activity of clusters, but pays
less attention to how clusters themselves respond to an
intervention directed at them, to how patients respond
to changes in care, or to unintended consequences [19].
We believe it is useful for designers of cluster-
randomised trials of complex interventions to start with
a broad overview of all potential candidates, and to
clearly justify why some candidates are selected for
detailed examination, and the methods and theories
chosen to examine selected processes.
Further work is required to develop critical appraisal
instruments for process evaluation studies; our proposed
criteria for reporting process evaluations represent mini-
mal requirements. We believe they will be helpful whilst
more empirically-based criteria for quality assessments
are developed, as have been established for the reporting
[28] and quality assessment of trials [42].
There is no single best way to conduct a process
evaluation, and researchers will usually need to make
choices about which research questions to focus on and
which methods to use. We recommend that researchers
explicitly state the purpose of their process evaluation
and demarcate its limits by clearly stating which pro-
cesses are being examined. We propose our framework
to facilitate this. Although we focus on process evalua-
tions of cluster-randomised trials, elements of the frame-
work are applicable to other study designs for evaluating
complex interventions. Process evaluations are complex,
diverse and face differing constraints based on the main
trial context and study funding. However, a more struc-
tured approach to process evaluation design and repor-
ting will improve the validity and dissemination of such
studies.
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